Transoral Robotic Surgery (TORS) for Cancer of Unknown Primary

Kyle Hatten, MD, Associate Professor of Otorhinolaryngology at the University of Maryland School of Medicine and Chief of Robotic Surgery at the University of Maryland Greenebaum Comprehensive Cancer Center, offers transoral robotic surgery (TORS) to treat cancer of unknown primary (CUP). This approach not only offers minimally invasive removal of suspicious lymph nodes but it increases the chances that a patient’s primary tumor will be discovered.

“The TORS unknown primary approach has dramatically increased our yield in finding these cancers,” says Dr. Hatten. “In addition to that, it affords us the opportunity so that when we do find these cancers, we can clear them with an oncologic resection at the time of the diagnostic procedure as well.”

Physicians and Health Care Providers: For more information about managing patients with cancer of unknown primary, visit:
https://umms.org/ummc/pros/phy....sician-briefs/cancer